Neuphoria Therapeutics Inc. (NEUP) Operating cash flow 2023–2025
Neuphoria Therapeutics Inc. (NEUP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$77,229FY2025 · since FY2023: -$14.6M → $77,229
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $77,229 | +100.5% |
| FY2024 | -$14.7M | -0.3% |
| FY2023 | -$14.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice